Literature DB >> 14704814

[Tissue typing in perforating corneal transplantation].

J Wachtlin1, R Khaireddin, F Hoffmann.   

Abstract

The demand for matched corneal grafts has risen rapidly over the last years. One reason for this is the change in the judgement of the value of tissue and especially HLA typing for prevention of an immune reaction in perforating corneal transplantation. Besides HLA or major antigens, there are other immunologically relevant tissue surface molecules such as the non-MHC antigens of which blood groups and minor antigens are the most important. With regard to effective cost-benefit and waiting time-benefit analyses, differentiated matching strategies are needed to assure optimized utilization and allocation of the still unsatisfactory number of available corneal grafts. With special matching strategies, such as the calculation of the individual waiting time, the consideration of split, non-MHC and HLA antigens, additional HLA loci as well as so-called "permissible" and "taboo" mismatches, much more has to be taken into account in the future than just the numerical correspondence of HLA antigens. This will make it possible to turn from a pure numerical approach to a functional matching strategy. This review summarizes the discussion and different matching strategies, possibilities and limitations of HLA and tissue typing in perforating corneal transplantation.

Mesh:

Substances:

Year:  2003        PMID: 14704814     DOI: 10.1007/s00347-003-0934-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  75 in total

Review 1.  The immunology of corneal transplantation.

Authors:  J Y Niederkorn
Journal:  Dev Ophthalmol       Date:  1999

2.  Pretransplant and posttransplant antibodies in human corneal transplantation.

Authors:  R Roy; H M Boisjoly; E Wagner; A Langlois; P M Bernard; R Bazin; P A Laughrea; I Dubé
Journal:  Transplantation       Date:  1992-09       Impact factor: 4.939

3.  Skin.

Authors:  E J Eichwald; C R Silmser
Journal:  Transplant Bull       Date:  1955

4.  Influence of donor-recipient HLA-DR mismatches and OKT3 prophylaxis on cadaver kidney graft survival.

Authors:  P Vereerstraeten; E Dupont; M Andrien; L De Pauw; D Abramowicz; M Goldman; P Kinnaert
Journal:  Transplantation       Date:  1995-08-15       Impact factor: 4.939

Review 5.  Advances in DNA-based HLA-typing methods.

Authors:  J Bidwell
Journal:  Immunol Today       Date:  1994-07

6.  Immunogenetic basis for immunologic privilege in the anterior chamber of the eye.

Authors:  J Y Niederkorn; J A Shadduck; J W Streilein
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  Association between HLA-DPB1 matching and 1-year rejection-free graft survival in high-risk corneal transplantation.

Authors:  B Munkhbat; M Hagihara; T Sato; F Tsuchida; K Sato; J Shimazaki; K Tsubota; K Tsuji
Journal:  Transplantation       Date:  1997-04-15       Impact factor: 4.939

8.  Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide.

Authors:  K Bendtzen; N Morling; A Fomsgaard; M Svenson; B Jakobsen; N Odum; A Svejgaard
Journal:  Scand J Immunol       Date:  1988-11       Impact factor: 3.487

9.  HLA matching and corneal grafting.

Authors:  J R Batchelor; T A Casey; A Werb; D C Gibbs; S S Prasad; D F Lloyd; A James
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

Review 10.  Future HLA matching strategies in clinical transplantation.

Authors:  Frans H J Claas; Dave L Roelen; Machteld Oudshoorn; Ilias I N Doxiadis
Journal:  Dev Ophthalmol       Date:  2003
View more
  3 in total

Review 1.  [Immunomodulation in penetrating keratoplasty. Current status and perspectives].

Authors:  U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

Review 3.  [Typing for HLA matching. Advantages for keratoplasty].

Authors:  R Ignatius; F Hoffmann
Journal:  Ophthalmologe       Date:  2007-03       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.